Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold
NCT ID: NCT02162056
Last Updated: 2020-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
326 participants
INTERVENTIONAL
2013-11-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Plaque Stabilization and Restoration by Bioresorbable Vascular Scaffold
NCT02319733
Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina
NCT02707783
BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease
NCT02932553
To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels
NCT01977534
Safety and Feasibility of the Injectable BL-1040 Implant
NCT00557531
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
use of bioresorbable vascular scaffolds
Implantation of bioresorbable vascular scaffold for coronary artery disease.
use of bioresorbable vascular scaffolds
Implantation of bioresorbable vascular scaffolds for coronary artery disease.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
use of bioresorbable vascular scaffolds
Implantation of bioresorbable vascular scaffolds for coronary artery disease.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* implantation of at least one bioresorbable vascular scaffold
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Ulm
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jochen Wohrle
Prof. Dr. Jochen Wöhrle
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jochen Wöhrle, MD
Role: PRINCIPAL_INVESTIGATOR
University of Ulm, Ulm, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Ulm
Ulm, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Reichart C, Wohrle J, Markovic S, Rottbauer W, Seeger J. Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique. BMC Cardiovasc Disord. 2019 Jan 18;19(1):22. doi: 10.1186/s12872-018-0994-y.
Markovic S, Kugler C, Rottbauer W, Wohrle J. Long-term clinical results of bioresorbable absorb scaffolds using the PSP-technique in patients with and without diabetes. J Interv Cardiol. 2017 Aug;30(4):325-330. doi: 10.1111/joic.12392. Epub 2017 Jun 1.
Markovic S, Dragomir S, Walcher D, Bernhardt P, Imhof A, Rottbauer W, Wohrle J. Clinical results of single and multiple bioresorbable drug-eluting scaffolds for treatment of de-novo coronary artery disease. Coron Artery Dis. 2016 Nov;27(7):561-5. doi: 10.1097/MCA.0000000000000392.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSI-Ulm-BVS 1.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.